Heron Therapeutics (HRTX) vs Verrica Pharmaceuticals (VRCA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Verrica Pharmaceuticals (VRCA) has outperformed Heron Therapeutics (HRTX) over the past year, losing 10.2% versus a loss of 70.9%. Over five years, HRTX leads with a -96.4% price change compared with -96.9% for VRCA. Heron Therapeutics is the larger company by market cap ($73.0 million vs $71.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HRTX | VRCA |
|---|---|---|
| Share price | $0.3843 | $4.14 |
| Market cap | $72.96M | $71.12M |
| 1-day change | +15.86% | -1.66% |
| YTD return | -70.44% | -50.18% |
| 1-year return | -70.89% | -10.20% |
| 5-year return | -96.37% | -96.90% |
| EPS (TTM) | $-0.21 | $-1.71 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.58 | $9.82 |
| 52-week low | $0.26 | $3.28 |
| Distance from 52-week high | -75.68% | -57.85% |
| Average volume | 2.57M | 62.77K |
| Shares outstanding | 189.85M | 17.18M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- VRCA has outperformed HRTX by 60.7 percentage points over the past year.
HRTX vs VRCA FAQ
Which is bigger, Heron Therapeutics or Verrica Pharmaceuticals?
Heron Therapeutics (HRTX) is larger, with a market capitalization of $72.96M compared with $71.12M for Verrica Pharmaceuticals (VRCA).
Which stock has performed better over the past year, HRTX or VRCA?
VRCA returned -10.20% over the past 12 months, compared with -70.89% for HRTX (price return, excluding dividends). Past performance does not predict future results.
Are Heron Therapeutics and Verrica Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.